COLLABORATE El Meu Clínic .This link opens in a new tab.
COLLABORATE El Meu Clínic .This link opens in a new tab.
Make a donation
Navigation thread
Navigation thread
Translational oncology in upper gastrointestinal cancers
Make a donation

Featured projects

  • Patient-derived models for the research and evaluation of discovery and innovation in combination therapies for biliary tract cancer (PREDICT-BC)

    Principal investigator: Tian Tian Tao.
    Funder: EU TRANSCAN-3 JTC2024.
    Duration: 01/10/2025 - 30/09/2028

  • Early-Onset Pancreatic Ductal Adenocarcinoma: A Comprehensive Multimodal Investigation (EOPC-ACMI)

    Principal investigator: Teresa Macarulla Mercadé.
    Funder: Asociación Española Contra el Cáncer (AECC).
    Duration: 01/01/2025 - 01/01/2029

  • COMBinATorial Personalized Approaches for Subtyping and Targeting Functional Heterogeneity in Pancreatic Ductal AdenoCarcinoma (COMBATPDAC). EP PerMed

    Principal investigator: Teresa Macarulla Mercadé.
    Funder: European Partnership for Personalized Medicine.
    Code: AC24/00045.
    Duration: 01/01/2025 - 01/01/2027

  • Pronóstico de Recurrencia Temprana Después de la Cirugía en Adenocarcinoma Ductal Pancreático Resecable y Borderline Resecable mediante Análisis Multi-Ómico

    Principal investigator: Teresa Macarulla Mercadé.
    Funder: Instituto de Salud Carlos III (ISCIII).
    Code: PI24/00526.
    Duration: 01/01/2025 - 01/01/2027

  • Desarrollo de nuevas estrategias para mejorar las terapias dirigidas del colangiocarcinoma

    Principal investigator: Tian Tian Tao.
    Funder: Ministerio de Ciencia, Innovación y Universidades.
    Code: PID2023_146827OB-I00.
    Duration: 01/01/2025 - 31/12/2027

  • Hacia una terapia de receptores de antígenos quiméricos de próxima generación para el colangiocarcinoma (TARQ-CCA)

    Funder: Fundació AstraZeneca.
    Duration: 01/11/2024 - 31/12/2026

  • TACTIC: Explorando soluciones a los retos de salud mediante ciencia disruptiva, therapias avanzadas y medicina de sistemes

    Principal investigator: Begoña Benito Villabriga.
    Funder: Instituto de Salud Carlos III (ISCIII).
    Code: FORT23/00034.
    Duration: 01/01/2024 - 01/01/2028

  • Exploring the Feasibility of predictive and pharmacodynamics biomarkers of immunotherapy in solid tumors (Immune4ALL)

    Principal investigator: Enrique de Alava.
    Funder: Instituto de Salud Carlos III (ISCIII).
    Code: PMP22/00054.
    Duration: 01/01/2023 - 01/01/2026

  • Deciphering epigenetic features hidden in the plasma of cholangiocarcinoma patients

    Principal investigator: Tian Tian Tao.
    Funder: FERO Foundation XXII edition Prize.
    Duration: 01/01/2023 - 31/12/2024

Major founders

The research of this group can be carried out thanks to the funders.

Contributors

Donations that make possible the research of this group.